Aurinia Pharmaceuticals auriniapharma.com

Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. We are currently developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerularsclerosis and minimal change disease (MCD). Additionally, we are advancing voclosporin ophthalmic solution (VOS), a topic formulation, for the treatment of dry eye syndrome (DES).

Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. We are currently developing voclosporin, an investigational drug, for the treatment of lupus nephri...Show all

See All Exits Recent Exits

Phone:

Fax:

#1203-4464 Markham Street

Victoria, V8Z 7X8
British Columbia, Canada

Aurinia Pharmaceuticals - Investments & Acquisitions

Show Real Data Aurinia Pharmaceuticals Investments
See all Recent Investments
Date Company Round Amount Co-investors
See all 0 investments